Status:
UNKNOWN
Dependence Receptors and Leukemia
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Acute Lymphoblastic Leukemia
Acute Leukemia
Eligibility:
All Genders
1-18 years
Brief Summary
Acute leukaemias (AL) are the first cause of cancer in children, with a majority of B acute lymphoblastic leukemia (ALL). Some of the processes causing leukemogenesis are already identified and well c...
Eligibility Criteria
Inclusion
- aged between 1 and 18 years
- taken care of at the Institute of Hematology and Pediatric Oncology (Service of Professor Yves Bertrand, IHOPe)
- for acute lymphoblastic or myeloblastic leukemia
- initial diagnosis or relapse
- who do not have a vital emergency criterion at the time of taking care (see exclusion criteria)
- affiliated to a social security scheme (100% assumed)
- after signing the informed consent of the holders of parental authority
Exclusion
- less than 1 year, or more than 18 years to diagnosis
- with chronic leukemia
- severe anemia at diagnosis (hemoglobin \<40g / l), or a state of shock whatever the cause (infectious, cardiogenic, hypovolemic)
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03278145
Start Date
November 1 2017
End Date
November 1 2019
Last Update
September 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut d'Hématologie et d'Oncologie Pédiatrique
Lyon, France, 69008